A 65-year-old man presents with symptoms of erythrodermic psoriasis flare
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss
Plus, rheumatology drug news from EULAR 2014
Spondyloarthritis: Clues to Earlier Recognition
Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting discuss challenges to diagnosing, managing spondyloarthritides
Rheumatology Drug Updates, Trials, Safety Data
Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know
How Rheumatologists Can Connect with Congressional Lawmakers during August Recess
Tips on scheduling in-office meetings in legislators’ home districts and which issues to discuss
Approval Expected for Apremilast
New drug shows promise in treating psoriatic arthritis, ankylosing spondylitis & psoriasis
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
2013 ACR/ARHP Annual Meeting: Genetic Research Yields Clues to Pathogenesis of Rheumatoid Arthritis, Psoriatic Arthritis
Studies determine that both RA and PsA are autoimmune diseases and link disease susceptibility to certain alleles that encode the major histocompatibility complex, HLA
Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors
Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease
EULAR 2013: Researchers Expand Targets for PsA, OA Therapy
Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis